News

Is there a role for e-cigarettes among adults who have not been able to stop using combustible cigarettes after using FDA-approved medication?

Working with people with brain tumors brings great satisfaction to South Carolina's only neuro-oncologists.

Three MUSC occupational therapy students are passionate about elevating the profession's role in cancer care.

The South Carolina Rare Disease Council hosted a symposium that gathered rare disease researchers and advocates to chart the path forward for improved care.

South Carolinians interested in cancer survivorship - as providers, researchers, caregivers or survivors - are invited to the first SCOR symposium in June.

Meningioma doesn't attract as much research as other types of brain tumors. But Dr. Ben Strickland believes his patients deserve more options.

Patrick Flume, M.D., was recently honored with the Cystic Fibrosis Foundation's 2024 Impact Award.

MUSC Health-Florence is one of four sites in the Southeast chosen for the Equitable Breakthroughs in Medicine Development Initiative.

CAR-T-cell therapy can be a powerful treatment for blood cancers, but it also has significant side effects. A clinical trial at Hollings seeks to change that.

MUSC will be one of four sites exploring the genetic basis of Parkinson’s disease in the Black community.